Escherichia coli general NAD(P)H:flavin oxidoreductase does not contain any bound flavin cofactor (1, 2). This property separates Fre 1 from the flavin-containing NAD(P)H:flavin oxidoreductases of Vibrio harveyi and V. fischeri that supply FMNH 2 to bacterial luciferases (3, 4). Fre uses either NADH or NADPH as electron donors to reduce FAD, FMN, or riboflavin (Rfl); however, when FAD is the electron acceptor, the K m values for NADH and NADPH are exceptionally large (1, 2, 5). Reduced flavins generated by Fre are believed to have important biological functions. It has been shown that the reduced flavins generated by Fre can regulate the activity of the aerobic ribonucleotide reductases by regenerating or scavenging the Tyr 122 radical of the ribonucleotide reductase in vitro (1, 6). An E. coli fre mutant is more susceptible to hydroxyurea, a scavenger of the Tyr 122 radical, than the wild-type E. coli (7), pointing to the protective role of Fre for the aerobic ribonucleotide reductase in vivo. Fre produces reduced flavins that can reduce metal ions, including ferrisiderophores (8), Cob(II-I)alamin (9), and chromate (10). Fre is capable of supplying FADH 2 to the FADH 2 -utilizing monooxygenases (11, 12). Despite these apparent biological functions, the genuine physiological role of Fre remains unclear.
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Recently, Ingelman et al. (13) reported the crystal structure of Fre with or without bound Rfl, revealing that Fre is similar to members of the ferredoxin:NADP ϩ reductase family in structure, although the similarities in amino acid sequence between Fre and members of the ferredoxin:NADP ϩ reductase family are low. The crystal structure shows that Fre is organized into an N-terminal flavin-binding domain and a C-terminal NAD(P)H-binding domain; the secondary structures of the two domains are labeled as F and N, respectively. The most interesting feature is that the loop connecting F␤5 and F␣1 in the flavin-binding domain that normally interacts with the ADP moiety of FAD in other ferredoxin:NADP ϩ reductases is exceptionally short in Fre (13) . Consequently, although FAD is a bound cofactor in most ferredoxin:NADP ϩ reductase proteins, all three flavin substrates of Fre do not remain bound (13) . Because the crystal structure of the Fre⅐Rfl complex revealed the interactions between the isoalloxazine ring of Rfl and the flavin-binding domain (12) and because the K m values of Fre for Rfl, FMN, and FAD are very similar (2) , it has been proposed that all three flavins mainly interact with residues of the flavin-binding domain through the isoalloxazine ring. However, direct experimental data are unavailable to support the proposed interactions of Fre with FMN and FAD.
In this report we characterized FAD and FMN binding to Fre. The K d values of Fre with FAD and FMN were determined. The value with FAD was much smaller than that with FMN or Rfl. Molecular dynamics (MD) simulations of Fre with FAD predicted that the ribityl side chain and the ADP moiety of FAD confer extra stability to the Fre⅐FAD complex. Experimental data supported the simulation model. Studies on the physiological roles of the high affinity of Fre for FAD revealed that FAD is a preferred substrate and inhibitor of Fre. An in vivo model for regulating Fre activities in responding to O 2 supply is proposed.
EXPERIMENTAL PROCEDURES

Materials
All reagents were of the highest purity available and were purchased from Sigma, Aldrich, or Fisher Scientific Co.
Overproduction and Purification of Proteins
HpaB, an FADH 2 -utilizing 4-hydroxyphenylacetate 3-monooxygenase, was overproduced and purified from E. coli BL21(DE3) carrying pES2 (11) . Overexpression of the cloned fre gene in E. coli BL21(DE3)(pES1) and purification of Fre were done primarily as reported previously (11) . To ensure Fre of the highest purity, a phenylagarose chromatography was added to the previously reported procedures. The ammonium sulfate precipitated proteins were dissolved in 20 mM KPi buffer (pH 7.0) containing 1 mM DTT with 25% saturation of ammonium sulfate and loaded onto a phenyl-agarose (Sigma) column (1.5 ϫ 12.5 cm) equilibrated with the same buffer. The proteins were eluted with a linear gradient of ammonium sulfate (25% to 0%, 200 ml) in KPi buffer with 1 mM DTT at a flow rate of 1 ml⅐min
Ϫ1
. Active fractions eluted with ϳ10% saturation of ammonium sulfate were pooled together and dialyzed against several changes of 20 mM KPi buffer (pH 7.0) with 1 mM DTT overnight. The sample was then purified by going through a Bioscale Q column and Superdex 75 column as reported previously (11) . Purified protein was analyzed by SDS-PAGE (14) .
Mass Spectrometry of Fre
ESI-MS was done with a Waters Micromass ZQ mass spectrometer. Fre samples in 10 mM Tris-HCl buffer (pH 7.5) were acidified with formic acid to a final concentration of 0.1% (v/v) and infused into the electrospray ionization source at a flow rate of 10 l⅐min Ϫ1 . The electrospray ionization source temperature and the desolvation temperature were maintained at 90°C and 150°C, respectively. The capillary voltage and the cone voltage were 3400 V and 35 V, respectively. Spectra were scanned from m/z 800 to 3000 at a rate of 1 scan/s. Protein mass spectrum was deconvoluted using the MaxEnt software (Waters). 
Enzyme Assays
HPLC Analysis of Fre
A HPLC system equipped with a photodiode array detector (Waters) and a Biosep Sec-S3000 size-exclusion column (7.8 ϫ 300 mm; Phenomenex) was used to estimate the fraction of Fre molecules that contained tightly bound flavins. Pure Fre (200 g) was eluted from the column with an isocratic flow of 20 mM KPi (pH 7.0) buffer with 1 mM DTT at 0.5 ml⅐min
Ϫ1
. The amount of flavin co-eluted with Fre was estimated by comparing the elution peak area of Fre derived at 450 nm with the elution peak area of free flavin standards. The same HPLC system equipped with a Delta Pak C 18 -300Å reverse phase column (3.9 ϫ 150 mm; Waters) was used to determine the nature of the tightly bound flavin. Fre sample (80 g) was eluted from the column with a 33-ml linear gradient of acetonitrile in 0.1% trifluoroacetic acid (0 -70%) with a flow rate of 1 ml⅐min
. Retention time of the flavin dissociated from Fre was compared with those of free flavin standards.
Measurement of the Dissociation Constant
The dissociation constants, K d , of the Fre⅐FAD and Fre⅐FMN complexes were determined by a spectrofluorometric titration method using a spectrofluorometer (Jobin Ybon Fluorlog). A 48 M Fre solution in 20 mM KPi buffer (pH 7.4) was titrated with various amounts of flavin added from a 50 M stock solution, and the change in fluorescence after each addition of flavin was recorded. The excitation wavelength was set at 280 nm, and fluorescence emission of Fre was recorded from 300 to 400 nm at 5-nm intervals. Both excitation and emission monochromator slit widths were set at 5 nm. The fluorescence intensity of Fre was plotted against the ratio of initial concentration of FAD to Fre and fitted with the following equation
in which is a scaling constant to compare the model with experimental data, I 0 is the fluorescence intensity of Fre, [Fre] 0 is the initial concentration of Fre at that titration point, I 1 is the fluorescence intensity of the Fre⅐FAD complex, and x is the final concentration of the Fre⅐FAD complex. The value of x is calculated by the following equation.
The effect of AMP on the K d of Fre for FAD was also determined. The experimental setup was identical to that described above, except that 0.18 mM AMP was included in the solution.
MD Simulations
The initial geometries of the Fre⅐FAD and Fre⅐FMN complexes were based on the crystal structure of the Fre⅐Rfl complex (from Dr. Vincent Nivière of the Université Joseph Fourier). The complete protein sequence was reconstituted and annealed by MD simulations using the package GROMACS (15, 16) running on a dual-CPU Linux work station. MD simulations were performed in the presence of 4895 water molecules of simple point charge as solvent. Periodical conditions were imposed for the triclinic simulation box. The GROMOS-96 43a1 force field was used for the Fre⅐FMN simulation, whereas the GROMACS force field was used for the Fre⅐FAD simulation. After the initial energy minimization and subsequent relaxation runs, the system was allowed to further equilibrate for another 800 ps with Berendsen-type temperature (300 K) and pressure (1.0 atm) coupling to an external bath.
MD Trajectory Analysis
Hydrogen Bonding-A 1-ns trajectory was recorded for each of the Fre⅐FAD and Fre⅐FMN runs. Hydrogen bonding analyses between Fre and the flavin substrate were performed. A hydrogen bond is registered when the distance between the hydrogen bonding donor (OH and NH) and acceptor (O: and N:) is less than 0.25 nm.
Representative Structure-Root mean square deviation clustering analysis was performed every 5 ps along the trajectory to locate the representative structure for the complexes. In the full-linkage clustering algorithm, a structure is added to the existing cluster when its distance to any element of the cluster is less than the 0.1-nm cutoff. The 5-ps structures were categorized according to their root mean square deviation values. A structure from the middle of the root mean square deviation distribution was extracted from the MD trajectory as the representative configuration.
Kinetic Analysis of Fre
The inhibitory effects of FAD on Fre activity were examined in the presence of NADPH and FMN. Reciprocal initial velocities were plotted against the reciprocal substrate (NADPH or FMN) concentrations at various fixed concentrations of FAD to determine the nature of the inhibitions. Inhibition constants were then determined from the Michaelis-Menten plots fitted with Equation 3 (for competitive inhibition) and Equation 4 (for mixed inhibition)
using the GraFit 5.0 program (Erithacus Software Ltd.). The apparent kinetic parameters of Fre for the NADPH-FMN substrate pair were also determined from Michaelis-Menten plots fitted with the following equation
using the GraFit program.
RESULTS
Purity of Fre Preparation-Forty-five mg of Fre was purified from 289 mg of protein in the cell extracts. The protein was purified to apparent homogeneity. The purified Fre was acidified and analyzed by ESI-MS; the molecular weight of Fre was determined to be 26,115 Ϯ 5, which is practically identical to Fre's theoretical molecular weight of 26,111 calculated from the amino acid sequence. No other major molecular mass was detected by ESI-MS, further validating the purity of the Fre preparation. The purified Fre had a specific activity of 69,230 Ϯ 295 units⅐mg Ϫ1 when reducing FMN with NADH as the electron donor at 30°C. The highly concentrated and pure Fre had a pale yellow color, suggesting the possibility of flavins being bound to Fre. The specific flavin bound to Fre was further tested.
HPLC Analyses of Fre-When 200 g (ϳ8 nmol) of Fre was loaded onto an HPLC size-exclusion column, we detected a small amount of flavin co-eluted with the Fre based on the absorption spectrum recorded by the photodiode array detector (Fig. 1) . The flavin peak was centered at the beginning of the protein peak, consistent with the slightly larger molecular weight of the Fre⅐flavin complex as compared with that of Fre alone. After integrating the peak area of the flavin peak that co-eluted with Fre and comparing it with the peak area of free FMN standards, our data showed that ϳ0.13 nmol equivalent of FMN was co-eluted with Fre. When Fre was loaded onto a C 18 reverse phase HPLC column, the Fre-bound flavin was dissociated from the protein, with a retention time of 9.938 min (Fig. 2) . A typical absorption spectrum of a flavin molecule was clearly detected (Fig. 2, inset) (Fig. 3, inset) . The K d for FAD was determined to be 29 Ϯ 9 nM after plotting the fluorescence intensity of Fre against the ratio of the added FAD concentration to the initial Fre concentration (Fig. 3) . Using a similar methodology, the K d for FMN was determined to be 1.
Computer Modeling of Fre⅐FAD Complex-The low K d value for FAD is not consistent with the previous hypothesis that the isoalloxazine rings of the flavin substrates provide the major determinant for the binding of the three flavins to Fre and that the flavins have similar affinity for Fre (13) . We hypothesized that the ribityl moiety and the ADP moiety of FAD might interact with other structural elements in Fre and provide extra stability for the Fre⅐FAD complex. To test this hypothesis, the structure of the Fre⅐FAD complex was modeled by MD simulations. MD simulations showed that FAD could adopt an unusual bent conformation (Fig. 4A) ) were shown to form additional H-bonding with the ribityl side chain and the ADP moiety of FAD (Fig. 4B) . Specifically, the MD trajectory showed that there were 8.03 Ϯ 2.13 (3,600 (average) 0.5-ps snapshots of a 900-ns trajectory with S.D.) hydrogen bonds between the Fre protein matrix and the FAD substrate, whereas there were only 4.75 Ϯ 1.72 hydrogen bonds between Fre and FMN. The number of hydrogen bonds appeared to vary with time, reflecting the dynamic nature of the Fre⅐FAD complex. This is illustrated in Fig. 4B , in which we show two snapshots of the hydrogen-bonding network around FAD.
Inhibitory Effect of FAD on Fre-The computer modeling of the Fre⅐FAD complex suggested that the ADP moiety of FAD interacts dynamically with amino acid residues located at the proposed NAD(P)H-binding site. This hypothesis was further . A minor peak with maximal absorption at 450 nm (dashed line) was eluted from the column at 9.938 min, whereas a major peak with maximal absorption at 280 nm (solid line) was eluted from the column at 26.0 min. Inset, absorption spectrum of the 9.938-min peak with maximal absorptions at 372 and 450 nm. examined. The K d value for FAD was determined to be 83 Ϯ 25 nM in the presence of 0.18 mM AMP, a known competitive inhibitor of Fre with respect to NAD(P)H (with reported K i values ranging from 0.3 to 0.5 mM) (2, 5) . This K d value is almost 3 times larger than the K d value determined in the absence of AMP.
The effect of FAD as an inhibitor for Fre activity was studied using NADPH as the electron donor and FMN as the major electron acceptor. It has been reported that the K m,NADPH of Fre is 14,000 M with a k cat of 16 s Ϫ1 if FAD is the sole electron acceptor (5) . Because the highest concentration of NADPH used in our inhibitory study was 415 M, Fre did not have any detectable activity for FAD reduction due to the large K m,NADPH value. Because FAD was practically not a substrate for Fre under the assay conditions, its inhibitory effect on FMN reduction with NADPH was studied. The effect of FAD on the activity of Fre for FMN reduction with NADH as the electron donor was also studied. Because FAD reduction by Fre is much slower than FMN reduction when NADH is less than 100 M (5), the effect of FAD was studied by measuring the Fre activity under a fixed concentration of NADH (80 M) and FMN (10 M), with various FAD concentrations. FAD at 1 M reduced the rate of NADH consumption of Fre by 13%, and at 10 M, FAD reduced the rate by 45% (Fig. 6) . The decrease was shown to be due to the preferential reduction of FAD when the amount of produced FADH 2 was measured by HpaB, an FADH 2 -utilizing 4-hydroxyphenylacetate 3-monooxygenase that does not use FMNH 2 (11) . HpaB was used in excess to ensure ultimate usage of FADH 2 produced in the assay. After a 30-min incubation, 1.6 nmol of NADH was consumed, and 1.7 Ϯ 0.1 nmol (average of three samples Ϯ S.D.) of 3,4-dihydroxyphenylacetate was produced with FAD alone in the assay; whereas 1.4 Ϯ 0.1 nmol of the product was formed in the presence of equal concentrations of FMN and FAD. Therefore, about 82% of the NADH was used to reduce FAD under the assay conditions containing 5 M each of FAD and FMN, with the remainder used for FMN reduction.
DISCUSSION
Fre had a much higher affinity for FAD than for FMN. The K d value for the Fre⅐FAD complex (29 Ϯ 9 nM) was 52 times lower than that of FMN (1.5 Ϯ 0.2 M). The K d values for Rfl and lumichrome, a flavin analog, are 3.6 and 0.5 M (17, 18) . Thus, among its flavin substrates, Fre binds FAD the most tightly. The tight binding was also observed by the co-elution of FAD with Fre from the HPLC size-exclusion chromatography (Fig. 1) . Results of the MD simulations (Fig. 4A) showed that not only the isoalloxazine ring of FAD but also the ribityl side chain and the ADP moiety were involved in binding to Fre, offering theoretical support for tighter binding for FAD than for FMN of Rfl. On the basis of the crystallized Fre⅐Rfl structure, which shows only one direct H-bond from the 2Ј-OH of the ribityl side chain to the carbonyl oxygen of Pro 47 (on F␤4) (13), and the similar K m values for Rfl, FMN, and FAD, it has been hypothesized that Fre binds Rfl, FMN, and FAD mainly through the isoalloxazine ring (1, 13) . The proposed interaction is real for Rfl and FMN, but not for FAD. The MD simulations predicted the formation of 3.28 extra H-bonds on average from the ribityl side chain and ADP moiety of FAD with Fre (Fig.  4B) . Considering the energy of a typical H-bond to be 2.9 -7.2 kcal/mol (19) , the extra H-bonds in the Fre⅐FAD complex contribute to a significant stabilization energy (enthalpy) of 9.5-23.6 kcal/mol, in comparison with the Fre⅐FMN complex. This stabilization energy should be viewed as an upper bound, because entropy (e.g. the bent conformation and larger size of the FAD can increase the entropy of the Fre⅐FAD complex) will reduce the stabilization. This view is consistent with the extra stabilization energy (free energy) of 2.3 kcal/mol calculated from the determined K d values of the Fre⅐FAD complex relative to the Fre⅐FMN complex.
The bent conformation of FAD predicted by MD simulations is similar to the conformation adopted by the FAD prosthetic group in the E. coli flavodoxin reductase, in which FAD exhibits a U-shaped conformation (20) . Interestingly, the flavodoxin reductase also lacks a full-size adenosine-interacting loop connecting (Fig. 4) , whereas the dynamic interaction of Arg 46 with FAD is not presented in the snapshot. The flavodoxin reductase has a Trp 248 residue at the C terminus, which provides additional interaction with the adenine ring of FAD. Such a Trp residue is not present in the Fre C terminus and may partly explain why Fre does not bind FAD permanently, whereas the flavodoxin reductase does.
Unlike the experimentally verified flavin-binding site, the NAD(P)H-binding site of Fre is only a proposed model (13) based on comparisons with different ferredoxin:NADP ϩ reductase⅐AMP complexes (21, 22) . The adenine ring and the ribose group of the 2Ј-phospho-ADP moiety of NADPH are proposed to bind to Fre near the amino ends of the ␣-helices of the NAD(P)H-binding domain, and Arg 202 and His 144 may bind the pyrophosphate group of NAD(P)H (13) . Interestingly, our MD simulations also predicted amino acid residues at these regions, such as Gln 143 and Arg 202 , to form H-bonds with the ADP moiety of FAD (Fig. 4B) . The overlapping binding sites of FAD and NAD(P)H were supported by several lines of results. Firstly, 0.18 mM AMP, a known competitive inhibitor with respect to the NAD(P)H (2, 5), increased the K d value of the Fre⅐FAD complex from 29 nM to 83 nM. In comparison, NADP ϩ or 3-aminopyridine adenosine dinucleotide phosphate, an NADPH analog, has no effect on the K d of Fre for Rfl (18) . AMP affects the binding of FAD to Fre probably by competing with the ADP moiety of FAD for the NAD(P)H-binding site, leading to an increased K d .
Secondly, kinetic analysis showed that FAD behaves as a competitive inhibitor with respect to FMN and a mixed-type inhibitor with respect to NADPH (Fig. 5) . Competitive inhibition of FAD upon FMN is expected because FAD should compete with FMN for the flavin-binding site. However, the mixedtype inhibition upon NADPH supports the MD simulation model. Lumichrome, an Fre-competitive inhibitor with respect to Rfl, is an uncompetitive inhibitor with respect to NADPH (2). Hence, lumichrome does not inhibit the formation of Fre⅐NADPH complex. The interactions between the ADP moiety of FAD and residues at the NAD(P)H-binding site may inhibit the formation of Fre⅐NADPH complex, leading to the observed mixed-type inhibitory effect.
The bent conformation of FAD also provides a plausible explanation for the extremely large K m,NADH (301 M) and K m,NADPH (14,000 M) values during FAD reduction, in comparison with the corresponding K m values for Rfl and FMN reduction (1, 2, 5) . Because FAD binds tightly to Fre through both the isoalloxazine ring and the ADP moiety (Fig. 4) , NADH has to compete with the ADP moiety of FAD for the binding site. Consequently, a higher concentration of NADH is required to outcompete the ADP moiety of FAD for the NAD(P)H-binding site, leading to a larger K m,NADH value than that for Rfl and FMN reduction. In the bent conformation, the negatively charged pyrophosphate group of FAD is also located in close proximity to the proposed binding site for the 2Ј-phosphate group of NADPH (13) (Fig. 4A) . The highly negatively charged pyrophosphate group may destabilize the binding of NADPH through repulsion with the negatively charged 2Ј-phosphate group of NADPH. Thus, the K m,NADPH value is 46 times larger than the K m,NADH when FAD is the electron acceptor. The single phosphate group of FMN may also destabilize NADPH binding to Fre by the same mechanism, resulting in a K m,NADPH of 418 Ϯ 41 M (calculated from Fig. 5) ; whereas the K m,NADH is merely 14.9 Ϯ 0.8 M during FMN reduction (data not shown).
The high affinity of Fre for FAD may imply that the in vivo Fre activity is much lower than previously expected under aerobic conditions. NADH and NADPH concentrations inside aerobically growing E. coli have been reported in the range of 20 and 150 M, respectively (23) . Intracellular free Rfl, FMN, and FAD concentrations have not been clearly defined. Only one study reports the internal free FAD concentration of Amphibacillus xylanus to be 13 M (24). Intracellular Rfl concentration should be much lower than those of FMN and FAD because Rfl should be transformed into the coenzyme forms FMN and FAD in order to fulfill its metabolic purpose (25) . Assuming the internal free FMN and FAD concentrations to be in the order of ϳ10 M, then in vivo Fre activity should be mainly due to the preferential reduction of FAD by NADH as demonstrated by our in vitro assay (Fig. 6 ) and the Fre-HpaB coupled assay. Fre literally cannot use NADPH to reduce FAD in vivo because the K m,NADPH value is much higher than the internal NADPH concentration. Thus, the in vivo Fre activity should be suppressed due to the low internal NADH concentration in comparison with the K m,NADH value. The low in vivo Fre activity is advantageous to the organism because this prevents unrestrained production of FADH 2 , wasteful reoxidation of the labile FADH 2 , and excessive production of detrimental reactive oxygen species such as H 2 O 2 (26) .
In summary, this study demonstrated that FAD binds more tightly to Fre than either FMN or Rfl does. The tight binding likely makes FAD the preferred substrate under in vivo conditions (Fig. 6 ). Experimental data and MD simulations suggested that the tight binding is due to an unusual bent conformation of FAD, allowing additional interactions between FAD and Fre. The ADP moiety of FAD likely competes with NAD(P)H for binding to Fre, explaining the large K m values for NADH and NADPH during FAD reduction. E. coli is a facultative anaerobe, growing both aerobically and anaerobically. When E. coli grows with sufficient O 2 supply, the intracellular NADH concentration is about 20 M, or 2% of total NADH and NAD ϩ (23) . The low NADH concentration supports very low Fre activity for FAD reduction, and FAD also inhibits FMN reduction by Fre. Thus, our data suggest that Fre activities are likely suppressed in aerobically growing E. coli cells.
